Frontotemporal lobar degeneration (FTLD) represents a group of neurodegenerative brain
diseases with highly heterogeneous clinical, neuropathological and genetic characteristics …

The last decade marked a turning point in the knowledge of frontotemporal lobar
degenerations (FTLD). Major discoveries were made with the identification of TDP-43 and …

Great strides have been made in the last 2 years in the field of frontotemporal lobar
degeneration (FTLD), particularly with respect to the genetics and molecular biology of FTLD …

Frontotemporal lobar degeneration (FTLD) is a heterogeneous group of disorders
characterized by disturbances of behavior and personality and different types of language …

Genetic diagnosis of frontotemporal lobar degeneration has become challenging since the
identification of a number of autosomal dominantly inherited causative mutations. As …

Frontotemporal lobar degeneration (FTLD) is a syndromic diagnosis that encompasses at
least three different variants. Imaging modalities are clinically useful in FTLD, although …

Frontotemporal lobar degeneration (FTLD) is a group of disorders that principally affect the
frontal and temporal lobes of the brain. In many parts of the world, FTLD is rapidly becoming …

The clinical disorders associated with frontotemporal lobar degeneration (FTLD) are
increasingly recognized as an important cause of early-onset dementia. Patients usually …

Frontotemporal lobar degeneration with TAR DNA-binding protein 43 inclusions (FTLD-
TDP) is the most common pathology associated with frontotemporal dementia (FTD). Repeat …

Genetic research in frontotemporal lobar degeneration (FTLD) is gaining momentum.
Following the discovery of a repeat expansion in the gene C9 open reading frame 72 …